Pars Planitis

Complex MONDO:0011644 Pathograph 18 Show in embeddings browser Inflammatory Disorder Ophthalmic Disorder

Pars planitis is a chronic intermediate uveitis defined by inflammation centered on the pars plana and peripheral retina, where characteristic "snowbank" exudates and vitreous "snowball" opacities form. It is an idiopathic, presumed autoimmune process in which T cell-driven inflammation of the peripheral uvea and adjacent vitreous causes vascular leakage and cellular infiltration. The resulting chronic inflammation predisposes to cystoid macular edema, the principal cause of vision loss, along with cataract, epiretinal membrane, and peripheral retinal neovascularization, and it shows an association with multiple sclerosis.

Ask OpenScientist

Ask a research question about Pars Planitis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🏷

Classifications

Harrison's Part
IMMUNE RHEUMATOLOGIC
👪

Inheritance

1
Multifactorial Susceptibility HP:0001426
Pars planitis arises sporadically with non-Mendelian multifactorial immunogenetic susceptibility involving HLA-DR2, HLA-DR15, HLA-B51, and HLA-DRB1*0802 haplotypes and other immune genes.
Multifactorial inheritance
Show evidence (2 references)
PMID:27051493 SUPPORT Other
"Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
Documents HLA haplotype associations supporting immunogenetic susceptibility in pars planitis.
PMID:26438050 SUPPORT Other
"Snowbanks are formed as an effect of post inflammatory glial proliferation of fibrous astrocytes. There is also a genetic predisposition for pars planitis by human leukocyte antigen and several other genes."
Confirms multifactorial genetic predisposition involving HLA and other genes in pars planitis.
◆

Subtypes

1
Idiopathic Pars Planitis
Chronic intermediate uveitis with snowballs and snowbanks in the absence of an identifiable underlying systemic disease or infection.
Show evidence (1 reference)
PMID:39360991 SUPPORT Other
"Pars planitis is the term used for idiopathic intermediate uveitis that presents with snowballs and snowbanks."
This represents the classic form of pars planitis where no underlying cause can be identified.
⚙

Pathophysiology

5
Autoimmune T-Cell Predominant Inflammation
Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.
T cell CL:0000084 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves T cell (CL:0000084). CL:0000084 is a cell type from the Cell Ontology.
Adaptive immune response GO:0002250 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Adaptive immune response (GO:0002250). GO:0002250 is a biological process from the Gene Ontology.
Vitreous humor UBERON:0001797 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Vitreous humor (UBERON:0001797). UBERON:0001797 is an anatomical location from the Uberon multi-species anatomy ontology. Pars plana UBERON:0001775 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Pars plana, annotated with ciliary body (UBERON:0001775). UBERON:0001775 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Vitreous Cell Infiltration T-cell predominant autoimmune activation drives cellular infiltration into the vitreous cavity.
Snowbank Formation at Pars Plana Chronic T-cell inflammation at the pars plana leads to post-inflammatory glial proliferation of fibrous astrocytes forming snowbanks.
Peripheral Retinal Vasculitis and Sheathing Intraocular inflammation in pars planitis is frequently accompanied by peripheral retinal vasculitis and venular sheathing.
Optic Disc Swelling Intraocular inflammation in pars planitis frequently produces angiographic or clinical optic disc edema.
Cataract Chronic intraocular inflammation in pars planitis frequently leads to complicated cataract formation.
Retinal Pigmentation Abnormality (Bone Spicules) Severe or prolonged intraocular inflammation in pars planitis can rarely be followed by progressive intraretinal bone-spicule pigmentation mimicking retinitis pigmentosa.
Show evidence (2 references)
PMID:26438050 SUPPORT Other
"Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."
Shows T-cell predominance in ocular infiltrates supporting autoimmune pathogenesis.
PMID:37976519 SUPPORT Other
"Pars planitis refers to the idiopathic subset of intermediate uveitis in which there is vitritis along with snowball or snowbank formation occurring in the absence of an associated infection or systemic disease. It is thought to be a T-cell mediated disease with a genetic predisposition."
Confirms T-cell mediated immunopathogenesis and genetic susceptibility in pars planitis.
Vitreous Cell Infiltration
Dense inflammatory cell infiltration and haze within the vitreous cavity.
T cell CL:0000084 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves T cell (CL:0000084). CL:0000084 is a cell type from the Cell Ontology.
Inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Vitreous humor UBERON:0001797 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Vitreous humor (UBERON:0001797). UBERON:0001797 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Vitreous Opacities Aggregation of inflammatory cells in the mid-vitreous and inferior peripheral vitreous forms yellow-white snowball opacities.
Floaters Vitreous inflammatory cells and snowball opacities are associated with presenting floater symptoms.
Blurred Vision Vitreous inflammation and haze contribute to blurred vision at presentation.
Visual Impairment Aggregation of floaters in the vitreous can cause significant visual loss in severe cases.
Show evidence (2 references)
PMID:27051493 SUPPORT Other
"Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis. Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."
Documents vitreous cell infiltration, haze, and yellow-white inflammatory snowball aggregates as defining findings.
PMID:28389773 SUPPORT Human clinical
"Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
Confirms high prevalence of vitreous inflammation and snowballs in clinical cohorts.
Snowbank Formation at Pars Plana
Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.
Astrocyte CL:0000127 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Astrocyte (CL:0000127). CL:0000127 is a cell type from the Cell Ontology.
Extracellular matrix organization GO:0030198 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Extracellular matrix organization (GO:0030198). GO:0030198 is a biological process from the Gene Ontology.
Pars plana UBERON:0001775 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Pars plana, annotated with ciliary body (UBERON:0001775). UBERON:0001775 is an anatomical location from the Uberon multi-species anatomy ontology. Peripheral retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Peripheral retina, annotated with retina (UBERON:0000966). UBERON:0000966 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Vitreous Opacities Exudative snowbanks on the inferior pars plana and associated vitreous base inflammation accompany characteristic vitreous opacities.
Show evidence (2 references)
PMID:26438050 SUPPORT Other
"Snowbanks are formed as an effect of post inflammatory glial proliferation of fibrous astrocytes. There is also a genetic predisposition for pars planitis by human leukocyte antigen and several other genes."
Explains the cellular mechanism of snowbank formation via post-inflammatory glial proliferation of fibrous astrocytes.
PMID:28389773 SUPPORT Human clinical
"Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
Shows snowbanks as a frequent structural manifestation of pars planitis at the pars plana.
Peripheral Retinal Vasculitis and Sheathing
Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.
Endothelial cell of vascular tree CL:0002139 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Endothelial cell of vascular tree (CL:0002139). CL:0002139 is a cell type from the Cell Ontology.
Inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Peripheral retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Peripheral retina, annotated with retina (UBERON:0000966). UBERON:0000966 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Macular Thickening from Blood-Retinal Barrier Breakdown Retinal vascular inflammation and perivasculitis are evaluated alongside cystoid macular edema on fluorescein angiography.
Show evidence (3 references)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Sheathing of peripheral retinal venules is another common clinical finding in patients with intermediate uveitis"
Notes sheathing of peripheral retinal venules as a common clinical finding in intermediate uveitis.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"The frequency of retinal vasculitis is variable, ranging from 17% to 90% in previous studies."
Summarizes the reported frequency range (17% to 90%) of retinal vasculitis across published pars planitis series.
PMID:28389773 SUPPORT Human clinical
"Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
Confirms high frequency of peripheral vascular sheathing in clinical series.
Macular Thickening from Blood-Retinal Barrier Breakdown
Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema and secondary epiretinal membrane formation.
Endothelial cell of vascular tree CL:0002139 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Endothelial cell of vascular tree (CL:0002139). CL:0002139 is a cell type from the Cell Ontology.
Regulation of vascular permeability GO:0043114 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Regulation of vascular permeability (GO:0043114). GO:0043114 is a biological process from the Gene Ontology.
Macula of retina UBERON:0000053 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Macula of retina, annotated with macula lutea (UBERON:0000053). UBERON:0000053 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Macular Edema Chronic macular inflammation and thickening frequently cause cystoid macular edema.
Epiretinal Membrane Chronic macular inflammation and macular edema lead to secondary epiretinal membrane formation.
Visual Impairment Macular thickening and cystoid macular edema degrade visual acuity in intermediate uveitis.
Blurred Vision Macular involvement in pars planitis contributes to presenting blurred vision.
Show evidence (2 references)
PMID:27188332 SUPPORT Human clinical
"The cut-off value of CFT for initiating systemic treatment was determined at 215.5 μm in a post hoc analysis (sensitivity 62.5 %, specificity 96.4 %)."
Shows that macular thickening beyond a threshold prompts treatment due to risk of vision loss in intermediate uveitis.
PMID:33559832 SUPPORT Human clinical
"According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."
OCT-defined diffuse macular edema and foveal contour loss predict worse visual acuity, underscoring the impact of macular thickening.
⬡

Pathograph

Use Group by to collapse related nodes into one box. Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Pars Planitis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

9
Blurred Vision VERY_FREQUENT Sensory HP:0000622 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Blurred vision (HP:0000622). HP:0000622 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
Blurred vision is a leading presenting symptom, reported in 74% of cases at diagnosis by Donaldson et al.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Prieto et al showed even higher rates of blurred vision (81.8%), while floaters were rarely reported (9%)."
Documents blurred vision in 81.8% of cases in the Prieto et al. series.
Floaters VERY_FREQUENT Sensory HP:0100832 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Vitreous floaters (HP:0100832). HP:0100832 is a phenotype from the Human Phenotype Ontology.
Dark spots or strings that appear to float in the visual field
Show evidence (1 reference)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
Floaters are among the predominant presenting symptoms of pars planitis (61% at diagnosis in Donaldson et al.).
Visual Impairment FREQUENT Sensory HP:0000505 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Visual impairment (HP:0000505). HP:0000505 is a phenotype from the Human Phenotype Ontology.
May progress to severe vision loss if untreated
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Although pars planitis is known to be a benign form of uveitis in most cases, it may become a potentially blinding disease due to complications including cataract, cystoid macular edema, vitreous opacities and optic disc edema."
Chronic inflammation can lead to complications that threaten vision if not controlled.
Vitreous Opacities FREQUENT Ocular HP:0004327 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal vitreous humor morphology (HP:0004327). HP:0004327 is a phenotype from the Human Phenotype Ontology.
Inflammatory debris and snowball aggregates in the vitreous chamber
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis. Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."
Vitreous opacities such as snowballs are typical inflammatory findings in pars planitis.
Macular Edema FREQUENT Ocular HP:0040049 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Macular edema (HP:0040049). HP:0040049 is a phenotype from the Human Phenotype Ontology.
Cystoid macular edema is the most common cause of visual morbidity
Show evidence (1 reference)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"In the study by Prieto et al, however, the most common complication of pars planitis was cystoid macular edema (47.7%), closely followed by vitreous opacities (38.6%), optic disc edema (38.6%) and vasculitis (36.4%)."
Macular edema is a frequent complication (47.7% in Prieto et al.) that can lead to permanent vision loss.
Cataract FREQUENT Ocular HP:0000518 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cataract (HP:0000518). HP:0000518 is a phenotype from the Human Phenotype Ontology.
Frequent ocular complication of chronic inflammation and corticosteroid therapy, reported in 30.4% to 47.5% of patients.
Show evidence (1 reference)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"In the majority of studies, cataracts were the most frequent reported complication of pars planitis occurring at high rates ranging from 30.4% to 47.5%."
Documents cataract as the most frequently reported complication across pars planitis series (30.4% to 47.5%).
Epiretinal Membrane FREQUENT Ocular HP:0100014 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Epiretinal membrane (HP:0100014). HP:0100014 is a phenotype from the Human Phenotype Ontology.
Chronic macular sequela occurring in up to 36.9% of patients at a mean interval of 7.9 years after disease onset.
Show evidence (1 reference)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Donaldson et al observed epiretinal membranes in 36.9% of subjects as the most common complication in their series, followed by cataract (30.4%) and cystoid macular edema (26%). Epiretinal membrane formation was found to be directly related to disease chronicity, and the mean interval between..."
Quantifies epiretinal membrane frequency (36.9%) and chronicity (mean 7.9 years from onset) in pars planitis.
Optic Disc Swelling FREQUENT Ocular HP:0001085 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Optic disc edema, annotated with Papilledema (HP:0001085). HP:0001085 is a phenotype from the Human Phenotype Ontology.
Inflammatory involvement of the optic nerve head observed clinically or on fluorescein angiography.
Show evidence (1 reference)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Optic disc edema is also common, found in around 70% of the cases when fluorescein angiography is performed."
Optic disc edema is a frequent inflammatory finding in pars planitis (around 70% on fluorescein angiography).
Retinal Pigmentation Abnormality (Bone Spicules) VERY_RARE Ocular HP:0007703 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormality of retinal pigmentation, annotated with Abnormal retinal pigmentation (HP:0007703). HP:0007703 is a phenotype from the Human Phenotype Ontology.
Inflammatory pseudo-retinitis pigmentosa pattern following pars planitis episodes
Show evidence (1 reference)
PMID:30200907 SUPPORT Human clinical
"He was diagnosed with bilateral pars planitis. Progressive, intraretinal bone crepuscule pigmentation developed in his left retina during the following three months. An electroretinogram showed subnormal response only in the left eye, suggesting the diagnosis of unilateral pseudoRP."
Describes bone spicule-like pigmentation emerging after bilateral pars planitis, mimicking retinitis pigmentosa.
🧬

Genetic Associations

2
HLA-DR15 (Risk Factor)
Gene: HLA-DRB1 hgnc:4948 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is HLA-DRB1 (hgnc:4948). hgnc:4948 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
HLA-DR15 has been linked to immunogenetic susceptibility in pars planitis.
HLA-B51 (Risk Factor)
Gene: HLA-B hgnc:4932 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is HLA-B (hgnc:4932). hgnc:4932 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
HLA-B51 is reported among haplotypes associated with pars planitis, supporting a genetic component.
💊

Medical Actions

4
Corticosteroids
Action: systemic corticosteroid therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is systemic corticosteroid therapy (NCIT:C122080). NCIT:C122080 is a clinical intervention from the NCI Thesaurus. Ontology label: Systemic Corticosteroid Therapy NCIT:C122080
Agent: triamcinolone CHEBI:9667 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses triamcinolone (CHEBI:9667). CHEBI:9667 is a therapeutic agent from Chemical Entities of Biological Interest. prednisone CHEBI:8382 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses prednisone (CHEBI:8382). CHEBI:8382 is a therapeutic agent from Chemical Entities of Biological Interest.
First-line treatment for reducing inflammation in pars planitis.
Target Phenotypes: Vitreous Opacities HP:0004327 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Vitreous Opacities, annotated with Abnormal vitreous humor morphology (HP:0004327). HP:0004327 is a phenotype from the Human Phenotype Ontology. Macular Edema HP:0040049 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Macular Edema (HP:0040049). HP:0040049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"A stepladder approach including corticosteroids, immunosupressive agents, anti-tumor necrosis factor-alpha and pars plana vitrectomy and/or laser photocoagulation is the most commonly used method for treatment of pars planitis."
Corticosteroids form the foundation of treatment for pars planitis.
Immunosuppressive Agents
Action: immunosuppressive therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is immunosuppressive therapy (NCIT:C15261). NCIT:C15261 is a clinical intervention from the NCI Thesaurus. Ontology label: Immunosuppressive Therapy NCIT:C15261
Agent: methotrexate CHEBI:44185 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses methotrexate (CHEBI:44185). CHEBI:44185 is a therapeutic agent from Chemical Entities of Biological Interest. mycophenolate mofetil CHEBI:8764 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses mycophenolate mofetil (CHEBI:8764). CHEBI:8764 is a therapeutic agent from Chemical Entities of Biological Interest. azathioprine CHEBI:2948 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses azathioprine (CHEBI:2948). CHEBI:2948 is a therapeutic agent from Chemical Entities of Biological Interest. cyclosporin A CHEBI:4031 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses cyclosporin A (CHEBI:4031). CHEBI:4031 is a therapeutic agent from Chemical Entities of Biological Interest.
Second-line therapy for chronic or steroid-resistant cases.
Target Phenotypes: Vitreous Opacities HP:0004327 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Vitreous Opacities, annotated with Abnormal vitreous humor morphology (HP:0004327). HP:0004327 is a phenotype from the Human Phenotype Ontology. Macular Edema HP:0040049 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Macular Edema (HP:0040049). HP:0040049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Methotrexate is the most widely used first-line immunosuppressive agent in children with chronic non-infectious uveitis because of its long-term safety record and well tolerance."
Immunosuppressive agents, particularly methotrexate, provide steroid-sparing control for chronic cases.
Biological Therapy
Action: biologic therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is biologic therapy, annotated with Immunotherapy (NCIT:C15262). NCIT:C15262 is a clinical intervention from the NCI Thesaurus. Ontology label: Immunotherapy NCIT:C15262
Agent: adalimumab NCIT:C65216 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses adalimumab (NCIT:C65216). NCIT:C65216 is a therapeutic agent from the NCI Thesaurus. infliximab NCIT:C1789 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses infliximab (NCIT:C1789). NCIT:C1789 is a therapeutic agent from the NCI Thesaurus.
TNF-alpha inhibitors for refractory cases.
Target Phenotypes: Vitreous Opacities HP:0004327 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Vitreous Opacities, annotated with Abnormal vitreous humor morphology (HP:0004327). HP:0004327 is a phenotype from the Human Phenotype Ontology. Macular Edema HP:0040049 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Macular Edema (HP:0040049). HP:0040049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34568953 SUPPORT Human clinical
"ADA was initiated in 23 patients (38.9%) due to refractory uveitis and adverse effects to the corticosteroid and helped control intraocular inflammation and decrease the use of systemic steroids/immunosuppressives in 22 of 23 (95%) of patients who received ADA."
TNF-alpha inhibition with adalimumab controlled inflammation and enabled steroid-sparing in refractory cases.
Pars Plana Vitrectomy
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Surgery
Surgical intervention for severe vitreous opacities or complications.
Target Phenotypes: Vitreous Opacities HP:0004327 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Vitreous Opacities, annotated with Abnormal vitreous humor morphology (HP:0004327). HP:0004327 is a phenotype from the Human Phenotype Ontology. Visual Impairment HP:0000505 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Visual Impairment (HP:0000505). HP:0000505 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"A stepladder approach including corticosteroids, immunosupressive agents, anti-tumor necrosis factor-alpha and pars plana vitrectomy and/or laser photocoagulation is the most commonly used method for treatment of pars planitis."
Surgical intervention may be necessary for cases with severe vitreous involvement or complications.
🌍

Environmental Factors

1
Arboviral Infection (Chikungunya)
viral exposure ECTO:3000001 Environmental Conditions, Treatments and Exposures Ontology (ECTO) Relation: this environmental factor is this exposure This environmental factor is viral exposure, annotated with exposure to virus (ECTO:3000001). ECTO:3000001 is an exposure from the Environmental Conditions, Treatments and Exposures Ontology.
Arboviral infections such as chikungunya can present as intermediate uveitis and should be excluded before labeling idiopathic pars planitis.
Show evidence (1 reference)
PMID:28010143 SUPPORT Human clinical
"Exam revealed a unilateral intermediate uveitis, with an extensive work-up positive for chikungunya virus immunoglobulin M and G titers."
Demonstrates that chikungunya infection can manifest as intermediate uveitis, making viral screening important in suspected pars planitis.
🔬

Diagnosis

5
Dilated Fundus Examination (Positive)
Reveals characteristic snowballs and snowbanks
Show evidence (1 reference)
PMID:39360991 SUPPORT Other
"Awareness of the presentation and a dilated fundus examination in patients presenting with floaters is essential to the diagnosis."
Dilated fundus examination is essential for diagnosing intermediate uveitis and identifying the characteristic features of pars planitis.
Optical Coherence Tomography (OCT) (Positive)
Detects macular edema and monitors treatment response
Show evidence (2 references)
PMID:27051493 SUPPORT Other
"Chronic inflammation in pars planitis frequently causes cystoid macular edema. OCT is valuable in detecting macular edema and its sequelae such as cystoid changes, epiretinal membranes, macular hole and atrophy."
OCT is the gold standard for detecting and monitoring cystoid macular edema, the most important complication of pars planitis.
PMID:33559832 SUPPORT Human clinical
"According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."
OCT findings such as diffuse macular edema and foveal contour loss stratify visual risk and guide treatment intensity.
Fluorescein Angiography (Positive)
May show peripheral retinal vasculitis and capillary non-perfusion
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"Retinal fluorescein angiography (FA) is beneficial to show the activity of retinal vascular inflammation in pars planitis. FA is usually performed for two reasons in pars planitis: To assess the presence of cystoid macular edema and to examine retinal vasculature for signs of perivasculitis and..."
Fluorescein angiography is useful for documenting peripheral retinal vasculitis and cystoid macular edema in pars planitis.
SUN Classification Criteria (Positive)
Machine-learned classification emphasizes snowballs or snowbanks while excluding systemic causes such as multiple sclerosis, sarcoidosis, and syphilis.
Show evidence (1 reference)
PMID:33845006 SUPPORT Human clinical
"Key criteria for pars planitis included unilateral or bilateral intermediate uveitis with either 1) snowballs in the vitreous or 2) snowbanks on the pars plana."
Provides the core SUN Working Group criteria that define pars planitis among intermediate uveitides.
Aqueous Humor Exosome Profiling (Positive)
Large 90-120 nm exosome peaks in aqueous humor correlate with inflammatory pars planitis activity.
Show evidence (1 reference)
PMID:38155415 SUPPORT Human clinical
"An obvious peak of exomeres(size around 35 nm)was found in the patients with central retinal vein occlusion and vitreous hemorrhage. Flare-ups of large exosomes(size 90-120 nm)were found in the patients with the inflammatory ocular disease pars planitis."
Demonstrates that exosome size distribution in aqueous humor can help identify inflammatory pars planitis.
📈

Progression

2
Onset
Age: Childhood to young adulthood (mean 6-10 years in pediatric series; 22.6 years in population-based series)
Predominantly affects children and adolescents, with occurrence highest at 6 to 10 years of age and 85% of patients in pediatric referral series diagnosed at age 14 years or younger (mean symptom onset 6 years), whereas a 20-year population-based study reported a higher mean age at diagnosis of 22.6 years.
Show evidence (3 references)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Rosenberg et al reported that the occurrence of pars planitis was highest in children 6 to 10 years of age."
Documents the 6-to-10-year childhood peak occurrence window in pediatric series.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Arellanes-Garcia et al showed that 85% of patients were 14 years of age or younger at diagnosis, and that the mean age when symptoms began, was 6 years."
Defines the childhood and adolescent onset distribution in referral series.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"However, Donaldson et al reported a higher mean age of 22.6 years in a 20-year population-based study on pars planitis."
Captures the higher mean age at diagnosis observed in population-based ascertainment.
Chronic Relapsing or Smoldering Course
Approximately 10% have a self-limited course, 59% have a prolonged course with exacerbations, and 31% have a chronic smoldering course; cystoid macular edema develops at a mean interval of 5.7 years and epiretinal membrane at 7.9 years after onset.
Show evidence (3 references)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Smith et al reported that 10% of patients had a self-limited course, whereas 59% had a prolonged course with exacerbations and 31% had a chronic smoldering course with few episodes of exacerbations."
Characterizes the natural history distribution across self-limited, relapsing, and chronic smoldering disease trajectories.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"It is related to disease chronicity, with a reported interval of 5.7 years between disease onset and the development of cystoid macular edema."
Quantifies the mean 5.7-year interval from disease onset to cystoid macular edema development.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Epiretinal membrane formation was found to be directly related to disease chronicity, and the mean interval between disease onset and epiretinal membrane formation was 7.9 years."
Quantifies the mean 7.9-year interval from disease onset to epiretinal membrane formation.
📊

Prevalence

1
France and United States general population
Annual incidence 1.4–2.0 per 100,000 per year 1–9 per 100,000 per year
Annual incidence in population-based studies from France and the United States is 1.4 to 2.0 cases per 100,000 population per year. Within pediatric uveitis referral cohorts, pars planitis accounts for 5% to 26.7% of cases.
Show evidence (2 references)
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"The incidence and prevalence of the disease show great variability according to geographic, genetic and referral patterns of the patients. Its yearly incidence has been reported to be 1.4 - 2 cases per 100,000 population in studies conducted in France and United States (US)."
Reports annual incidence of 1.4 to 2 cases per 100,000 population per year in France and the United States.
PMID:27051493 SUPPORT REVIEW SYNTHESIS Human clinical
"Pars planitis is an idiopathic chronic intermediate uveitis which predominantly affects children and adolescents, and accounts for 5-26.7% of pediatric uveitis."
Establishes the proportion of pediatric uveitis cases attributable to pars planitis across clinical series.
🔀

Differential Diagnoses

6

Conditions with similar clinical presentations that must be differentiated from Pars Planitis:

Birdshot Retinochoroiditis Not Yet Curated MONDO:0011599
Overlapping Features Retinal vasculitis with HLA-A29 positivity can mimic intermediate uveitis but has a distinct angiographic signature.
Distinguishing Features
  • Scoring of retinal vasculitis features such as disc hyperfluorescence and profuse posterior leakage separates birdshot retinochoroiditis from pars planitis.
  • Confirmation of HLA-A29 antigen supports birdshot retinochoroiditis, whereas pars planitis has no HLA antigen requirement.
Show evidence (2 references)
PMID:40642353 SUPPORT Human clinical
"The control group included nine cases of sarcoidosis chorioretinitis, six cases of intermediate uveitis of the pars planitis type, two cases of Behçet uveitis, and one case of tuberculosis chorioretinitis. The mean scores for the BRC group were 10.5 ± 1.7, while in the control group, it was 3.9..."
Quantitative retinal vasculitis scoring distinguishes birdshot retinochoroiditis from pars planitis in comparative cohorts.
PMID:40642353 SUPPORT Human clinical
"Retinal vasculitis related to BRC has specific findings leading, if present, to the diagnosis of BRC that should be ascertained by the search of indocyanine green angiography lesions with the ultimate confirmation by the presence of the HLA-A29 antigen."
Specific vasculitis features plus HLA-A29 confirmation distinguish birdshot retinochoroiditis from pars planitis.
Retinoblastoma (Masquerade Syndrome) MONDO:0008380
Overlapping Features Retinoblastoma can present with vitreous seeding and mimic inflammatory vitreous snowballs seen in pars planitis.
Distinguishing Features
  • Presence of an intraocular mass with diffuse vitreous seeding rather than inflammatory snowballs.
  • Regression with intra-arterial or intravitreal chemotherapy instead of corticosteroid or immunosuppressive therapy.
Show evidence (1 reference)
PMID:41334298 SUPPORT Human clinical
"He had been diagnosed with the impression of pars planitis versus organized vitreous hemorrhage in another center and was referred to us 6 months later. Fundus examination with indirect ophthalmoscopy at our center revealed a fundus mass with diffuse vitreous seeding."
Demonstrates that a fundus mass with vitreous seeding signals retinoblastoma rather than inflammatory pars planitis.
Infectious Masquerade Intermediate Uveitis
Overlapping Features Infectious entities can mimic intermediate uveitis presentations and must be excluded before diagnosing idiopathic pars planitis.
Distinguishing Features
  • PCR testing and directed serologies identify infectious causes rather than idiopathic inflammation.
  • Targeted antimicrobial therapy improves infectious masquerade syndromes, unlike corticosteroid-responsive pars planitis.
Show evidence (1 reference)
PMID:39360991 SUPPORT Other
"PCR testing has enhanced the ability to diagnose infectious and neoplastic conditions that masquerade as intermediate uveitis."
Shows that molecular testing uncovers infectious causes that can mimic pars planitis.
Intraocular Lymphoma (Masquerade Syndrome) Not Yet Curated MONDO:0004351
Overlapping Features Primary intraocular lymphoma can imitate intermediate uveitis with vitreous cells and requires oncologic evaluation.
Distinguishing Features
  • Presence of malignant lymphoid cells in ocular fluid or tissue differentiates lymphoma from idiopathic inflammation.
  • Responds to oncologic therapy rather than corticosteroids alone.
Show evidence (1 reference)
PMID:27051493 SUPPORT Other
"In the elderly, primary intraocular lymphoma is the most important entity to be differentiated from pars planitis. It may present with diffuse vitreous infiltration, which may mimic intermediate uveitis."
Notes that primary intraocular lymphoma can masquerade as intermediate uveitis with diffuse vitreous infiltration and must be excluded.
Multiple Sclerosis-Associated Intermediate Uveitis MONDO:0005301
Overlapping Features Intermediate uveitis secondary to multiple sclerosis can resemble pars planitis but carries neurologic signs and demyelinating lesions.
Distinguishing Features
  • Neurologic symptoms and MRI-demonstrated demyelinating lesions support multiple sclerosis-associated uveitis rather than idiopathic pars planitis.
  • Workup for demyelinating disease is required when intermediate uveitis co-occurs with neurologic complaints.
Show evidence (1 reference)
PMID:33845006 SUPPORT Human clinical
"Key criteria for pars planitis included unilateral or bilateral intermediate uveitis with either 1) snowballs in the vitreous or 2) snowbanks on the pars plana. Key exclusions included: 1) multiple sclerosis, 2) sarcoidosis, and 3) syphilis."
The SUN criteria treat multiple sclerosis as an exclusion, underscoring the need to differentiate it from idiopathic pars planitis.
Sarcoidosis-Associated Intermediate Uveitis with Vasoproliferative Tumor MONDO:0019338
Overlapping Features Sarcoidosis-related intermediate uveitis can produce peripheral vasoproliferative tumors and exudative detachment, mimicking complicated pars planitis.
Distinguishing Features
  • Systemic sarcoidosis history with granulomatous uveitis plus a peripheral retinal vascular mass points to sarcoid-associated intermediate uveitis rather than idiopathic pars planitis.
  • Exudative retinal detachment arising from a vasoproliferative tumor that regresses with combined steroid-sparing immunosuppression, vitrectomy, and tumor-directed cryotherapy distinguishes this entity.
Show evidence (1 reference)
PMID:38645965 SUPPORT Human clinical
"She had active vitritis, and a peripheral retinal vascular mass was noted in the superotemporal periphery. The mass was associated with ERD involving the posterior pole."
Highlights sarcoidosis-associated intermediate uveitis complicated by vasoproliferative tumor and exudative detachment, requiring differentiation from idiopathic pars planitis.
{ }

Source YAML

click to show 
name: Pars Planitis
creation_date: '2026-01-08T01:24:35Z'
description: >-
  Pars planitis is a chronic intermediate uveitis defined by inflammation
  centered on the pars plana and peripheral retina, where characteristic
  "snowbank" exudates and vitreous "snowball" opacities form. It is an
  idiopathic, presumed autoimmune process in which T cell-driven inflammation of
  the peripheral uvea and adjacent vitreous causes vascular leakage and cellular
  infiltration. The resulting chronic inflammation predisposes to cystoid macular
  edema, the principal cause of vision loss, along with cataract, epiretinal
  membrane, and peripheral retinal neovascularization, and it shows an
  association with multiple sclerosis.
category: Complex
synonyms:
- Idiopathic intermediate uveitis
parents:
- Inflammatory Disorder
- Ophthalmic Disorder
classifications:
  harrisons_chapter:
  - classification_value: IMMUNE_RHEUMATOLOGIC
    evidence:
    - reference: PMID:26438050
      reference_title: "Immunopathogenic Background of Pars Planitis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."
      explanation: Establishes pars planitis as a T-cell predominant autoimmune inflammatory disorder.
inheritance:
- name: Multifactorial Susceptibility
  inheritance_term:
    preferred_term: Multifactorial inheritance
    term:
      id: HP:0001426
      label: Non-Mendelian inheritance
  description: >-
    Pars planitis arises sporadically with non-Mendelian multifactorial immunogenetic
    susceptibility involving HLA-DR2, HLA-DR15, HLA-B51, and HLA-DRB1*0802 haplotypes
    and other immune genes.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
    explanation: Documents HLA haplotype associations supporting immunogenetic susceptibility in pars planitis.
  - reference: PMID:26438050
    reference_title: "Immunopathogenic Background of Pars Planitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Snowbanks are formed as an effect of post inflammatory glial proliferation of fibrous astrocytes. There is also a genetic predisposition for pars planitis by human leukocyte antigen and several other genes."
    explanation: Confirms multifactorial genetic predisposition involving HLA and other genes in pars planitis.
prevalence:
- population: France and United States general population
  measure_type: ANNUAL_INCIDENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_denominator: POPULATION_PER_YEAR
  rate_low: 1.4
  rate_high: 2.0
  notes: >-
    Annual incidence in population-based studies from France and the United States
    is 1.4 to 2.0 cases per 100,000 population per year. Within pediatric uveitis
    referral cohorts, pars planitis accounts for 5% to 26.7% of cases.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "The incidence and prevalence of the disease show great variability according to geographic, genetic and referral patterns of the patients. Its yearly incidence has been reported to be 1.4 - 2 cases per 100,000 population in studies conducted in France and United States (US)."
    explanation: Reports annual incidence of 1.4 to 2 cases per 100,000 population per year in France and the United States.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Pars planitis is an idiopathic chronic intermediate uveitis which predominantly affects children and adolescents, and accounts for 5-26.7% of pediatric uveitis."
    explanation: Establishes the proportion of pediatric uveitis cases attributable to pars planitis across clinical series.
progression:
- phase: Onset
  age_range: Childhood to young adulthood (mean 6-10 years in pediatric series; 22.6 years in population-based series)
  notes: >-
    Predominantly affects children and adolescents, with occurrence highest at
    6 to 10 years of age and 85% of patients in pediatric referral series diagnosed
    at age 14 years or younger (mean symptom onset 6 years), whereas a 20-year
    population-based study reported a higher mean age at diagnosis of 22.6 years.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Rosenberg et al reported that the occurrence of pars planitis was highest in children 6 to 10 years of age."
    explanation: Documents the 6-to-10-year childhood peak occurrence window in pediatric series.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Arellanes-Garcia et al showed that 85% of patients were 14 years of age or younger at diagnosis, and that the mean age when symptoms began, was 6 years."
    explanation: Defines the childhood and adolescent onset distribution in referral series.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "However, Donaldson et al reported a higher mean age of 22.6 years in a 20-year population-based study on pars planitis."
    explanation: Captures the higher mean age at diagnosis observed in population-based ascertainment.
- phase: Chronic Relapsing or Smoldering Course
  notes: Approximately 10% have a self-limited course, 59% have a prolonged course with exacerbations, and 31% have a chronic smoldering course; cystoid macular edema develops at a mean interval of 5.7 years and epiretinal membrane at 7.9 years after onset.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Smith et al reported that 10% of patients had a self-limited course, whereas 59% had a prolonged course with exacerbations and 31% had a chronic smoldering course with few episodes of exacerbations."
    explanation: Characterizes the natural history distribution across self-limited, relapsing, and chronic smoldering disease trajectories.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "It is related to disease chronicity, with a reported interval of 5.7 years between disease onset and the development of cystoid macular edema."
    explanation: Quantifies the mean 5.7-year interval from disease onset to cystoid macular edema development.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Epiretinal membrane formation was found to be directly related to disease chronicity, and the mean interval between disease onset and epiretinal membrane formation was 7.9 years."
    explanation: Quantifies the mean 7.9-year interval from disease onset to epiretinal membrane formation.
has_subtypes:
- name: Idiopathic Pars Planitis
  description: Chronic intermediate uveitis with snowballs and snowbanks in the absence of an identifiable underlying systemic disease or infection.
  evidence:
  - reference: PMID:39360991
    reference_title: "Epidemiology of Intermediate Uveitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Pars planitis is the term used for idiopathic intermediate uveitis that presents with snowballs and snowbanks."
    explanation: This represents the classic form of pars planitis where no underlying cause can be identified.
pathophysiology:
- name: Autoimmune T-Cell Predominant Inflammation
  description: Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: Adaptive immune response
    term:
      id: GO:0002250
      label: adaptive immune response
  locations:
  - preferred_term: Vitreous humor
    term:
      id: UBERON:0001797
      label: vitreous humor
  - preferred_term: Pars plana
    term:
      id: UBERON:0001775
      label: ciliary body
  downstream:
  - target: Vitreous Cell Infiltration
    causal_link_type: DIRECT
    description: T-cell predominant autoimmune activation drives cellular infiltration into the vitreous cavity.
    evidence:
    - reference: PMID:26438050
      reference_title: "Immunopathogenic Background of Pars Planitis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."
      explanation: Demonstrates that T-cell predominant autoimmune inflammation directly populates the vitreous infiltrates.
  - target: Snowbank Formation at Pars Plana
    description: Chronic T-cell inflammation at the pars plana leads to post-inflammatory glial proliferation of fibrous astrocytes forming snowbanks.
    evidence:
    - reference: PMID:26438050
      reference_title: "Immunopathogenic Background of Pars Planitis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations. T cells subsets play an important role as a memory-effector peripheral cell. Snowbanks are formed as an effect of post inflammatory glial proliferation of fibrous astrocytes."
      explanation: Links T-cell predominant pars plana inflammation to post-inflammatory glial proliferation that forms snowbanks.
  - target: Peripheral Retinal Vasculitis and Sheathing
    description: Intraocular inflammation in pars planitis is frequently accompanied by peripheral retinal vasculitis and venular sheathing.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis. Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."
      explanation: Documents peripheral retinal vasculitis as a characteristic inflammatory manifestation of pars planitis alongside vitreous and pars plana inflammation.
  - target: Optic Disc Swelling
    description: Intraocular inflammation in pars planitis frequently produces angiographic or clinical optic disc edema.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "Optic disc edema is also common, found in around 70% of the cases when fluorescein angiography is performed."
      explanation: Documents optic disc edema as a frequent inflammatory manifestation in pars planitis.
  - target: Cataract
    description: Chronic intraocular inflammation in pars planitis frequently leads to complicated cataract formation.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "In the majority of studies, cataracts were the most frequent reported complication of pars planitis occurring at high rates ranging from 30.4% to 47.5%."
      explanation: Establishes cataract as the most frequent ocular complication of chronic pars planitis across clinical series.
  - target: Retinal Pigmentation Abnormality (Bone Spicules)
    description: Severe or prolonged intraocular inflammation in pars planitis can rarely be followed by progressive intraretinal bone-spicule pigmentation mimicking retinitis pigmentosa.
    evidence:
    - reference: PMID:30200907
      reference_title: "Progression of retinal pigmentation mimicking unilateral retinitis pigmentosa after bilateral pars planitis: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "He was diagnosed with bilateral pars planitis. Progressive, intraretinal bone crepuscule pigmentation developed in his left retina during the following three months. An electroretinogram showed subnormal response only in the left eye, suggesting the diagnosis of unilateral pseudoRP."
      explanation: Demonstrates that bilateral pars planitis can be followed by secondary intraretinal bone-spicule pigmentation.
  evidence:
  - reference: PMID:26438050
    reference_title: "Immunopathogenic Background of Pars Planitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."
    explanation: Shows T-cell predominance in ocular infiltrates supporting autoimmune pathogenesis.
  - reference: PMID:37976519
    reference_title: "Pediatric Pars Planitis: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Pars planitis refers to the idiopathic subset of intermediate uveitis in which there is vitritis along with snowball or snowbank formation occurring in the absence of an associated infection or systemic disease. It is thought to be a T-cell mediated disease with a genetic predisposition."
    explanation: Confirms T-cell mediated immunopathogenesis and genetic susceptibility in pars planitis.
- name: Vitreous Cell Infiltration
  description: Dense inflammatory cell infiltration and haze within the vitreous cavity.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  downstream:
  - target: Vitreous Opacities
    causal_link_type: DIRECT
    description: Aggregation of inflammatory cells in the mid-vitreous and inferior peripheral vitreous forms yellow-white snowball opacities.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Vitreous snowballs are yellow-white inflammatory aggregates usually found in the mid-vitreous and inferior peripheral vitreous"
      explanation: Directly defines vitreous snowballs as yellow-white inflammatory aggregates in the mid-vitreous and inferior peripheral vitreous.
  - target: Floaters
    description: Vitreous inflammatory cells and snowball opacities are associated with presenting floater symptoms.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
      explanation: Documents floaters as a frequent presenting symptom in pars planitis (61% in Donaldson et al.).
  - target: Blurred Vision
    description: Vitreous inflammation and haze contribute to blurred vision at presentation.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
      explanation: Documents blurred vision as a frequent presenting symptom in pars planitis (74% in Donaldson et al.).
  - target: Visual Impairment
    causal_link_type: DIRECT
    description: Aggregation of floaters in the vitreous can cause significant visual loss in severe cases.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "In severe cases, significant visual loss may occur due to aggregation of floaters in the vitreous or macular edema."
      explanation: Directly links aggregation of vitreous floaters to significant visual loss in severe pars planitis.
  biological_processes:
  - preferred_term: Inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  locations:
  - preferred_term: Vitreous humor
    term:
      id: UBERON:0001797
      label: vitreous humor
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis. Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."
    explanation: Documents vitreous cell infiltration, haze, and yellow-white inflammatory snowball aggregates as defining findings.
  - reference: PMID:28389773
    reference_title: "Analysis of clinical features and visual outcomes of pars planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
    explanation: Confirms high prevalence of vitreous inflammation and snowballs in clinical cohorts.
- name: Snowbank Formation at Pars Plana
  description: Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.
  cell_types:
  - preferred_term: Astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  downstream:
  - target: Vitreous Opacities
    description: Exudative snowbanks on the inferior pars plana and associated vitreous base inflammation accompany characteristic vitreous opacities.
    evidence:
    - reference: PMID:28613790
      reference_title: "Pars Planitis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Inflammation may be present in the anterior vitreous, the vitreous base overlying the peripheral retina-pars plana region. It is characterized by vitreal inflammatory aggregates (snowballs), and whitish exudates on the inferior pars plana (snowbanking)."
      explanation: Connects pars plana snowbank exudates and vitreous base inflammation to characteristic vitreous opacities.
  biological_processes:
  - preferred_term: Extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  locations:
  - preferred_term: Pars plana
    term:
      id: UBERON:0001775
      label: ciliary body
  - preferred_term: Peripheral retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:26438050
    reference_title: "Immunopathogenic Background of Pars Planitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Snowbanks are formed as an effect of post inflammatory glial proliferation of fibrous astrocytes. There is also a genetic predisposition for pars planitis by human leukocyte antigen and several other genes."
    explanation: Explains the cellular mechanism of snowbank formation via post-inflammatory glial proliferation of fibrous astrocytes.
  - reference: PMID:28389773
    reference_title: "Analysis of clinical features and visual outcomes of pars planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
    explanation: Shows snowbanks as a frequent structural manifestation of pars planitis at the pars plana.
- name: Peripheral Retinal Vasculitis and Sheathing
  description: Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.
  cell_types:
  - preferred_term: Endothelial cell of vascular tree
    term:
      id: CL:0002139
      label: endothelial cell of vascular tree
  downstream:
  - target: Macular Thickening from Blood-Retinal Barrier Breakdown
    description: Retinal vascular inflammation and perivasculitis are evaluated alongside cystoid macular edema on fluorescein angiography.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Retinal fluorescein angiography (FA) is beneficial to show the activity of retinal vascular inflammation in pars planitis. FA is usually performed for two reasons in pars planitis: To assess the presence of cystoid macular edema and to examine retinal vasculature for signs of perivasculitis and retinal neovascularization."
      explanation: Documents that retinal vascular inflammation (perivasculitis) and cystoid macular edema are jointly assessed as vascular inflammatory manifestations on fluorescein angiography.
  biological_processes:
  - preferred_term: Inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  locations:
  - preferred_term: Peripheral retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Sheathing of peripheral retinal venules is another common clinical finding in patients with intermediate uveitis"
    explanation: Notes sheathing of peripheral retinal venules as a common clinical finding in intermediate uveitis.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "The frequency of retinal vasculitis is variable, ranging from 17% to 90% in previous studies."
    explanation: Summarizes the reported frequency range (17% to 90%) of retinal vasculitis across published pars planitis series.
  - reference: PMID:28389773
    reference_title: "Analysis of clinical features and visual outcomes of pars planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%), anterior chamber cells (66.7%) and peripheral retinal vascular sheathing (48.1%) were the most common presentations."
    explanation: Confirms high frequency of peripheral vascular sheathing in clinical series.
- name: Macular Thickening from Blood-Retinal Barrier Breakdown
  description: Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema and secondary epiretinal membrane formation.
  cell_types:
  - preferred_term: Endothelial cell of vascular tree
    term:
      id: CL:0002139
      label: endothelial cell of vascular tree
  downstream:
  - target: Macular Edema
    causal_link_type: DIRECT
    description: Chronic macular inflammation and thickening frequently cause cystoid macular edema.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Chronic inflammation in pars planitis frequently causes cystoid macular edema. OCT is valuable in detecting macular edema and its sequelae such as cystoid changes, epiretinal membranes, macular hole and atrophy."
      explanation: Links chronic inflammation in pars planitis directly to cystoid macular edema detected on OCT.
  - target: Epiretinal Membrane
    description: Chronic macular inflammation and macular edema lead to secondary epiretinal membrane formation.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Chronic inflammation in pars planitis frequently causes cystoid macular edema. OCT is valuable in detecting macular edema and its sequelae such as cystoid changes, epiretinal membranes, macular hole and atrophy."
      explanation: Identifies epiretinal membranes as a recognized macular sequela of chronic inflammation and macular edema on OCT.
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "Epiretinal membrane formation was found to be directly related to disease chronicity, and the mean interval between disease onset and epiretinal membrane formation was 7.9 years."
      explanation: Shows that epiretinal membrane formation is directly related to disease chronicity in pars planitis.
  - target: Visual Impairment
    causal_link_type: DIRECT
    description: Macular thickening and cystoid macular edema degrade visual acuity in intermediate uveitis.
    evidence:
    - reference: PMID:27188332
      reference_title: "A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."
      explanation: Links central retinal thickening to worse visual acuity.
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "In severe cases, significant visual loss may occur due to aggregation of floaters in the vitreous or macular edema."
      explanation: Directly links macular edema to significant visual loss.
  - target: Blurred Vision
    description: Macular involvement in pars planitis contributes to presenting blurred vision.
    evidence:
    - reference: PMID:27051493
      reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
      explanation: Documents blurred vision as a frequent symptom in pars planitis (74% in Donaldson et al.).
  biological_processes:
  - preferred_term: Regulation of vascular permeability
    term:
      id: GO:0043114
      label: regulation of vascular permeability
  locations:
  - preferred_term: Macula of retina
    term:
      id: UBERON:0000053
      label: macula lutea
  evidence:
  - reference: PMID:27188332
    reference_title: "A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The cut-off value of CFT for initiating systemic treatment was determined at 215.5 μm in a post hoc analysis (sensitivity 62.5 %, specificity 96.4 %)."
    explanation: Shows that macular thickening beyond a threshold prompts treatment due to risk of vision loss in intermediate uveitis.
  - reference: PMID:33559832
    reference_title: "Spectral domain optical coherence tomography findings of patients with pars planitis and risk factors affecting visual acuity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."
    explanation: OCT-defined diffuse macular edema and foveal contour loss predict worse visual acuity, underscoring the impact of macular thickening.
phenotypes:
- category: Sensory
  name: Blurred Vision
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
    explanation: Blurred vision is a leading presenting symptom, reported in 74% of cases at diagnosis by Donaldson et al.
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Prieto et al showed even higher rates of blurred vision (81.8%), while floaters were rarely reported (9%)."
    explanation: Documents blurred vision in 81.8% of cases in the Prieto et al. series.
  phenotype_term:
    preferred_term: Blurred vision
    term:
      id: HP:0000622
      label: Blurred vision
- category: Sensory
  name: Floaters
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Dark spots or strings that appear to float in the visual field
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "The most common symptoms at presentation are floaters and blurred vision. Donaldson et al reported blurred vision in 74% and floaters in 61% of cases at the time of diagnosis."
    explanation: Floaters are among the predominant presenting symptoms of pars planitis (61% at diagnosis in Donaldson et al.).
  phenotype_term:
    preferred_term: Vitreous floaters
    term:
      id: HP:0100832
      label: Vitreous floaters
- category: Sensory
  name: Visual Impairment
  frequency: FREQUENT
  notes: May progress to severe vision loss if untreated
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Although pars planitis is known to be a benign form of uveitis in most cases, it may become a potentially blinding disease due to complications including cataract, cystoid macular edema, vitreous opacities and optic disc edema."
    explanation: Chronic inflammation can lead to complications that threaten vision if not controlled.
  phenotype_term:
    preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
- category: Ocular
  name: Vitreous Opacities
  frequency: FREQUENT
  notes: Inflammatory debris and snowball aggregates in the vitreous chamber
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis. Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."
    explanation: Vitreous opacities such as snowballs are typical inflammatory findings in pars planitis.
  phenotype_term:
    preferred_term: Abnormal vitreous humor morphology
    term:
      id: HP:0004327
      label: Abnormal vitreous humor morphology
- category: Ocular
  name: Macular Edema
  frequency: FREQUENT
  notes: Cystoid macular edema is the most common cause of visual morbidity
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "In the study by Prieto et al, however, the most common complication of pars planitis was cystoid macular edema (47.7%), closely followed by vitreous opacities (38.6%), optic disc edema (38.6%) and vasculitis (36.4%)."
    explanation: Macular edema is a frequent complication (47.7% in Prieto et al.) that can lead to permanent vision loss.
  phenotype_term:
    preferred_term: Macular edema
    term:
      id: HP:0040049
      label: Macular edema
- category: Ocular
  name: Cataract
  frequency: FREQUENT
  notes: Frequent ocular complication of chronic inflammation and corticosteroid therapy, reported in 30.4% to 47.5% of patients.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "In the majority of studies, cataracts were the most frequent reported complication of pars planitis occurring at high rates ranging from 30.4% to 47.5%."
    explanation: Documents cataract as the most frequently reported complication across pars planitis series (30.4% to 47.5%).
  phenotype_term:
    preferred_term: Cataract
    term:
      id: HP:0000518
      label: Cataract
- category: Ocular
  name: Epiretinal Membrane
  frequency: FREQUENT
  notes: Chronic macular sequela occurring in up to 36.9% of patients at a mean interval of 7.9 years after disease onset.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Donaldson et al observed epiretinal membranes in 36.9% of subjects as the most common complication in their series, followed by cataract (30.4%) and cystoid macular edema (26%). Epiretinal membrane formation was found to be directly related to disease chronicity, and the mean interval between disease onset and epiretinal membrane formation was 7.9 years."
    explanation: Quantifies epiretinal membrane frequency (36.9%) and chronicity (mean 7.9 years from onset) in pars planitis.
  phenotype_term:
    preferred_term: Epiretinal membrane
    term:
      id: HP:0100014
      label: Epiretinal membrane
- category: Ocular
  name: Optic Disc Swelling
  frequency: FREQUENT
  notes: Inflammatory involvement of the optic nerve head observed clinically or on fluorescein angiography.
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Optic disc edema is also common, found in around 70% of the cases when fluorescein angiography is performed."
    explanation: Optic disc edema is a frequent inflammatory finding in pars planitis (around 70% on fluorescein angiography).
  phenotype_term:
    preferred_term: Optic disc edema
    term:
      id: HP:0001085
      label: Papilledema
- category: Ocular
  name: Retinal Pigmentation Abnormality (Bone Spicules)
  frequency: VERY_RARE
  notes: Inflammatory pseudo-retinitis pigmentosa pattern following pars planitis episodes
  evidence:
  - reference: PMID:30200907
    reference_title: "Progression of retinal pigmentation mimicking unilateral retinitis pigmentosa after bilateral pars planitis: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He was diagnosed with bilateral pars planitis. Progressive, intraretinal bone crepuscule pigmentation developed in his left retina during the following three months. An electroretinogram showed subnormal response only in the left eye, suggesting the diagnosis of unilateral pseudoRP."
    explanation: Describes bone spicule-like pigmentation emerging after bilateral pars planitis, mimicking retinitis pigmentosa.
  phenotype_term:
    preferred_term: Abnormality of retinal pigmentation
    term:
      id: HP:0007703
      label: Abnormal retinal pigmentation
diagnosis:
- name: Dilated Fundus Examination
  presence: Positive
  notes: Reveals characteristic snowballs and snowbanks
  evidence:
  - reference: PMID:39360991
    reference_title: "Epidemiology of Intermediate Uveitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Awareness of the presentation and a dilated fundus examination in patients presenting with floaters is essential to the diagnosis."
    explanation: Dilated fundus examination is essential for diagnosing intermediate uveitis and identifying the characteristic features of pars planitis.
- name: Optical Coherence Tomography (OCT)
  presence: Positive
  notes: Detects macular edema and monitors treatment response
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Chronic inflammation in pars planitis frequently causes cystoid macular edema. OCT is valuable in detecting macular edema and its sequelae such as cystoid changes, epiretinal membranes, macular hole and atrophy."
    explanation: OCT is the gold standard for detecting and monitoring cystoid macular edema, the most important complication of pars planitis.
  - reference: PMID:33559832
    reference_title: "Spectral domain optical coherence tomography findings of patients with pars planitis and risk factors affecting visual acuity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."
    explanation: OCT findings such as diffuse macular edema and foveal contour loss stratify visual risk and guide treatment intensity.
- name: Fluorescein Angiography
  presence: Positive
  notes: May show peripheral retinal vasculitis and capillary non-perfusion
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Retinal fluorescein angiography (FA) is beneficial to show the activity of retinal vascular inflammation in pars planitis. FA is usually performed for two reasons in pars planitis: To assess the presence of cystoid macular edema and to examine retinal vasculature for signs of perivasculitis and retinal neovascularization."
    explanation: Fluorescein angiography is useful for documenting peripheral retinal vasculitis and cystoid macular edema in pars planitis.
- name: SUN Classification Criteria
  presence: Positive
  notes: Machine-learned classification emphasizes snowballs or snowbanks while excluding systemic causes such as multiple sclerosis, sarcoidosis, and syphilis.
  evidence:
  - reference: PMID:33845006
    reference_title: "Classification Criteria For Pars Planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Key criteria for pars planitis included unilateral or bilateral intermediate uveitis with either 1) snowballs in the vitreous or 2) snowbanks on the pars plana."
    explanation: Provides the core SUN Working Group criteria that define pars planitis among intermediate uveitides.
- name: Aqueous Humor Exosome Profiling
  presence: Positive
  notes: Large 90-120 nm exosome peaks in aqueous humor correlate with inflammatory pars planitis activity.
  evidence:
  - reference: PMID:38155415
    reference_title: "Isolation of three different sizes of exosomes in an Asian population with different retinal diseases before and after treatment: preliminary results."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "An obvious peak of exomeres(size around 35 nm)was found in the patients with central retinal vein occlusion and vitreous hemorrhage. Flare-ups of large exosomes(size 90-120 nm)were found in the patients with the inflammatory ocular disease pars planitis."
    explanation: Demonstrates that exosome size distribution in aqueous humor can help identify inflammatory pars planitis.
genetic:
- name: HLA-DR15
  gene_term:
    preferred_term: HLA-DRB1
    term:
      id: hgnc:4948
      label: HLA-DRB1
  association: Risk Factor
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
    explanation: HLA-DR15 has been linked to immunogenetic susceptibility in pars planitis.
- name: HLA-B51
  gene_term:
    preferred_term: HLA-B
    term:
      id: hgnc:4932
      label: HLA-B
  association: Risk Factor
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."
    explanation: HLA-B51 is reported among haplotypes associated with pars planitis, supporting a genetic component.
environmental:
- name: Arboviral Infection (Chikungunya)
  exposure_term:
    preferred_term: viral exposure
    term:
      id: ECTO:3000001
      label: exposure to virus
  effect: Potential trigger
  notes: Arboviral infections such as chikungunya can present as intermediate uveitis and should be excluded before labeling idiopathic pars planitis.
  evidence:
  - reference: PMID:28010143
    reference_title: "Chikungunya Virus Infection Manifesting as Intermediate Uveitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exam revealed a unilateral intermediate uveitis, with an extensive work-up positive for chikungunya virus immunoglobulin M and G titers."
    explanation: Demonstrates that chikungunya infection can manifest as intermediate uveitis, making viral screening important in suspected pars planitis.
treatments:
- name: Corticosteroids
  description: First-line treatment for reducing inflammation in pars planitis.
  examples:
  - Subtenon triamcinolone injection
  - Intravitreal triamcinolone
  - Oral prednisone
  target_phenotypes:
  - preferred_term: Vitreous Opacities
    term:
      id: HP:0004327
      label: Abnormal vitreous humor morphology
  - preferred_term: Macular Edema
    term:
      id: HP:0040049
      label: Macular edema
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A stepladder approach including corticosteroids, immunosupressive agents, anti-tumor necrosis factor-alpha and pars plana vitrectomy and/or laser photocoagulation is the most commonly used method for treatment of pars planitis."
    explanation: Corticosteroids form the foundation of treatment for pars planitis.
  treatment_term:
    preferred_term: systemic corticosteroid therapy
    term:
      id: NCIT:C122080
      label: Systemic Corticosteroid Therapy
    therapeutic_agent:
    - preferred_term: triamcinolone
      term:
        id: CHEBI:9667
        label: triamcinolone
    - preferred_term: prednisone
      term:
        id: CHEBI:8382
        label: prednisone
- name: Immunosuppressive Agents
  description: Second-line therapy for chronic or steroid-resistant cases.
  examples:
  - Methotrexate
  - Mycophenolate mofetil
  - Azathioprine
  - Cyclosporine
  target_phenotypes:
  - preferred_term: Vitreous Opacities
    term:
      id: HP:0004327
      label: Abnormal vitreous humor morphology
  - preferred_term: Macular Edema
    term:
      id: HP:0040049
      label: Macular edema
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Methotrexate is the most widely used first-line immunosuppressive agent in children with chronic non-infectious uveitis because of its long-term safety record and well tolerance."
    explanation: Immunosuppressive agents, particularly methotrexate, provide steroid-sparing control for chronic cases.
  treatment_term:
    preferred_term: immunosuppressive therapy
    term:
      id: NCIT:C15261
      label: Immunosuppressive Therapy
    therapeutic_agent:
    - preferred_term: methotrexate
      term:
        id: CHEBI:44185
        label: methotrexate
    - preferred_term: mycophenolate mofetil
      term:
        id: CHEBI:8764
        label: mycophenolate mofetil
    - preferred_term: azathioprine
      term:
        id: CHEBI:2948
        label: azathioprine
    - preferred_term: cyclosporin A
      term:
        id: CHEBI:4031
        label: cyclosporin A
- name: Biological Therapy
  description: TNF-alpha inhibitors for refractory cases.
  examples:
  - Adalimumab
  - Infliximab
  target_phenotypes:
  - preferred_term: Vitreous Opacities
    term:
      id: HP:0004327
      label: Abnormal vitreous humor morphology
  - preferred_term: Macular Edema
    term:
      id: HP:0040049
      label: Macular edema
  evidence:
  - reference: PMID:34568953
    reference_title: "Clinical characteristics and treatment of pars planitis: an adalimumab experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ADA was initiated in 23 patients (38.9%) due to refractory uveitis and adverse effects to the corticosteroid and helped control intraocular inflammation and decrease the use of systemic steroids/immunosuppressives in 22 of 23 (95%) of patients who received ADA."
    explanation: TNF-alpha inhibition with adalimumab controlled inflammation and enabled steroid-sparing in refractory cases.
  treatment_term:
    preferred_term: biologic therapy
    term:
      id: NCIT:C15262
      label: Immunotherapy
    therapeutic_agent:
    - preferred_term: adalimumab
      term:
        id: NCIT:C65216
        label: Adalimumab
    - preferred_term: infliximab
      term:
        id: NCIT:C1789
        label: Infliximab
- name: Pars Plana Vitrectomy
  description: Surgical intervention for severe vitreous opacities or complications.
  target_phenotypes:
  - preferred_term: Vitreous Opacities
    term:
      id: HP:0004327
      label: Abnormal vitreous humor morphology
  - preferred_term: Visual Impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A stepladder approach including corticosteroids, immunosupressive agents, anti-tumor necrosis factor-alpha and pars plana vitrectomy and/or laser photocoagulation is the most commonly used method for treatment of pars planitis."
    explanation: Surgical intervention may be necessary for cases with severe vitreous involvement or complications.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
differential_diagnoses:
- name: Birdshot Retinochoroiditis
  description: Retinal vasculitis with HLA-A29 positivity can mimic intermediate uveitis but has a distinct angiographic signature.
  distinguishing_features:
  - Scoring of retinal vasculitis features such as disc hyperfluorescence and profuse posterior leakage separates birdshot retinochoroiditis from pars planitis.
  - Confirmation of HLA-A29 antigen supports birdshot retinochoroiditis, whereas pars planitis has no HLA antigen requirement.
  disease_term:
    preferred_term: birdshot chorioretinopathy
    term:
      id: MONDO:0011599
      label: birdshot chorioretinopathy
  evidence:
  - reference: PMID:40642353
    reference_title: "Specific retinal vasculitis in HLA-A29 birdshot retinochoroiditis, distinguishing it from other causes of vasculitis: A pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The control group included nine cases of sarcoidosis chorioretinitis, six cases of intermediate uveitis of the pars planitis type, two cases of Behçet uveitis, and one case of tuberculosis chorioretinitis. The mean scores for the BRC group were 10.5 ± 1.7, while in the control group, it was 3.9 ± 2.8 (P < 0.0001, t-test)."
    explanation: Quantitative retinal vasculitis scoring distinguishes birdshot retinochoroiditis from pars planitis in comparative cohorts.
  - reference: PMID:40642353
    reference_title: "Specific retinal vasculitis in HLA-A29 birdshot retinochoroiditis, distinguishing it from other causes of vasculitis: A pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Retinal vasculitis related to BRC has specific findings leading, if present, to the diagnosis of BRC that should be ascertained by the search of indocyanine green angiography lesions with the ultimate confirmation by the presence of the HLA-A29 antigen."
    explanation: Specific vasculitis features plus HLA-A29 confirmation distinguish birdshot retinochoroiditis from pars planitis.
- name: Retinoblastoma (Masquerade Syndrome)
  description: Retinoblastoma can present with vitreous seeding and mimic inflammatory vitreous snowballs seen in pars planitis.
  distinguishing_features:
  - Presence of an intraocular mass with diffuse vitreous seeding rather than inflammatory snowballs.
  - Regression with intra-arterial or intravitreal chemotherapy instead of corticosteroid or immunosuppressive therapy.
  disease_term:
    preferred_term: retinoblastoma
    term:
      id: MONDO:0008380
      label: retinoblastoma
  evidence:
  - reference: PMID:41334298
    reference_title: "Unveiling the Hidden Threat: Late-Onset Retinoblastoma Mimicking Pars Planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had been diagnosed with the impression of pars planitis versus organized vitreous hemorrhage in another center and was referred to us 6 months later. Fundus examination with indirect ophthalmoscopy at our center revealed a fundus mass with diffuse vitreous seeding."
    explanation: Demonstrates that a fundus mass with vitreous seeding signals retinoblastoma rather than inflammatory pars planitis.
- name: Infectious Masquerade Intermediate Uveitis
  description: Infectious entities can mimic intermediate uveitis presentations and must be excluded before diagnosing idiopathic pars planitis.
  distinguishing_features:
  - PCR testing and directed serologies identify infectious causes rather than idiopathic inflammation.
  - Targeted antimicrobial therapy improves infectious masquerade syndromes, unlike corticosteroid-responsive pars planitis.
  evidence:
  - reference: PMID:39360991
    reference_title: "Epidemiology of Intermediate Uveitis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "PCR testing has enhanced the ability to diagnose infectious and neoplastic conditions that masquerade as intermediate uveitis."
    explanation: Shows that molecular testing uncovers infectious causes that can mimic pars planitis.
- name: Intraocular Lymphoma (Masquerade Syndrome)
  description: Primary intraocular lymphoma can imitate intermediate uveitis with vitreous cells and requires oncologic evaluation.
  distinguishing_features:
  - Presence of malignant lymphoid cells in ocular fluid or tissue differentiates lymphoma from idiopathic inflammation.
  - Responds to oncologic therapy rather than corticosteroids alone.
  disease_term:
    preferred_term: intraocular lymphoma
    term:
      id: MONDO:0004351
      label: intraocular lymphoma
  evidence:
  - reference: PMID:27051493
    reference_title: "Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In the elderly, primary intraocular lymphoma is the most important entity to be differentiated from pars planitis. It may present with diffuse vitreous infiltration, which may mimic intermediate uveitis."
    explanation: Notes that primary intraocular lymphoma can masquerade as intermediate uveitis with diffuse vitreous infiltration and must be excluded.
- name: Multiple Sclerosis-Associated Intermediate Uveitis
  description: Intermediate uveitis secondary to multiple sclerosis can resemble pars planitis but carries neurologic signs and demyelinating lesions.
  distinguishing_features:
  - Neurologic symptoms and MRI-demonstrated demyelinating lesions support multiple sclerosis-associated uveitis rather than idiopathic pars planitis.
  - Workup for demyelinating disease is required when intermediate uveitis co-occurs with neurologic complaints.
  disease_term:
    preferred_term: multiple sclerosis
    term:
      id: MONDO:0005301
      label: multiple sclerosis
  evidence:
  - reference: PMID:33845006
    reference_title: "Classification Criteria For Pars Planitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Key criteria for pars planitis included unilateral or bilateral intermediate uveitis with either 1) snowballs in the vitreous or 2) snowbanks on the pars plana. Key exclusions included: 1) multiple sclerosis, 2) sarcoidosis, and 3) syphilis."
    explanation: The SUN criteria treat multiple sclerosis as an exclusion, underscoring the need to differentiate it from idiopathic pars planitis.
- name: Sarcoidosis-Associated Intermediate Uveitis with Vasoproliferative Tumor
  description: Sarcoidosis-related intermediate uveitis can produce peripheral vasoproliferative tumors and exudative detachment, mimicking complicated pars planitis.
  distinguishing_features:
  - Systemic sarcoidosis history with granulomatous uveitis plus a peripheral retinal vascular mass points to sarcoid-associated intermediate uveitis rather than idiopathic pars planitis.
  - Exudative retinal detachment arising from a vasoproliferative tumor that regresses with combined steroid-sparing immunosuppression, vitrectomy, and tumor-directed cryotherapy distinguishes this entity.
  disease_term:
    preferred_term: sarcoidosis
    term:
      id: MONDO:0019338
      label: sarcoidosis
  evidence:
  - reference: PMID:38645965
    reference_title: "Vasoproliferative Tumor Secondary to Sarcoidosis-Associated Intermediate Uveitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She had active vitritis, and a peripheral retinal vascular mass was noted in the superotemporal periphery. The mass was associated with ERD involving the posterior pole."
    explanation: Highlights sarcoidosis-associated intermediate uveitis complicated by vasoproliferative tumor and exudative detachment, requiring differentiation from idiopathic pars planitis.
disease_term:
  preferred_term: pars planitis
  term:
    id: MONDO:0011644
    label: pars planitis